Skip to main content
. 2022 Oct 19;102:4367. doi: 10.2340/actadv.v102.4367

Fig. 3.

Fig. 3

Pathophysiology of lichen simplex chronicus and its therapeutic targets. AMPs: antimicrobial peptides; JAK-STAT: janus kinase-signal transducer and activator of transcription; IL: interleukin; PAR-2: protease-activated receptor 2; SSRIs: selective serotonin reuptake inhibitors; TENS: transcutaneous electrical nerve stimulation; Th: T-helper cell; TRPV: transient receptor potential vanilloid; 5-HT: serotonin.